Asbestos exposure and antineutrophil cytoplasmic antibody (ANCA) positivity

被引:21
|
作者
Pelclová, D
Bartunková, J
Fenclová, Z
Lebedová, J
Hladíková, M
Benáková, H
机构
[1] Charles Univ Prague, Dept Occupat Med, Fac Med 1, Prague 12000, Czech Republic
[2] Gen Teaching Hosp, Inst Clin Biochem, Prague 12000, Czech Republic
[3] Charles Univ Prague, Fac Med 2, Dept Med Informat, Prague 12000, Czech Republic
[4] Charles Univ Prague, Fac Med 2, Inst Immunol, Prague 12000, Czech Republic
来源
ARCHIVES OF ENVIRONMENTAL HEALTH | 2003年 / 58卷 / 10期
关键词
antibodies; asbestos; Czech Republic; occupational health;
D O I
10.3200/AEOH.58.10.662-668
中图分类号
X [环境科学、安全科学];
学科分类号
08 ; 0830 ;
摘要
The authors used indirect immunofluorescence to examine the association of antineutrophil cytoplasmic antibodies (ANCAs) with exposure to asbestos among 61 asbestos-exposed patients (mean exposure = 24.6 yr) and 39 nonexposed controls. ANCA positivity was detected significantly more frequently (p = 0.034) in the asbestos-ex posed group (21.3%) than in the control group (5.1%). ANCA-associated diseases did not occur more frequently among subjects exposed previously to asbestos than among unexposed controls. These findings confirmed that exposure to asbestos is another occupational factor, as is silica exposure, that is associated with ANCA positivity. The influence of asbestos appears stronger than that of silica because ANCA positivity was found among subjects who had histories of exposure to asbestos but who did not exhibit typical radiographic signs of asbestosis on their chest x-rays. Additional stimuli may be necessary to induce systemic vasculitis in asbestos-ex posed persons.
引用
收藏
页码:662 / 668
页数:7
相关论文
共 50 条
  • [1] Fibrogenic dusts and ANCA (Antineutrophil Cytoplasmic Antibodies) positivity
    Pelclová, D
    Bartunková, J
    Fenclová, Z
    Lebedová, J
    Hladíková, M
    Janu, P
    Marel, M
    [J]. CHEST, 2003, 124 (04) : 214S - 214S
  • [2] Unclassifiable repeated antineutrophil cytoplasmic antibody (ANCA) positivity in diseases other than ANCA-associated vasculitis
    Choi, Hyeok
    Park, Yong-Beom
    Song, Jaewoo
    Lee, Sang-Won
    [J]. ZEITSCHRIFT FUR RHEUMATOLOGIE, 2022, 81 (08): : 705 - 711
  • [3] A CASE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)-ASSOCIATED VASCULITIS
    Smith, Jodi-Ann S.
    Grant-Sittol, Janeen
    Wright, Joel W.
    Sadiq, Mehjabeen
    Brijmohan, Sharmela
    Fleischer, Joseph
    Patel, Dipal R.
    [J]. CHEST, 2022, 162 (04) : 1818A - 1819A
  • [4] Antineutrophil cytoplasmic antibody (ANCA)-associated crescentic glomerulonephritis
    Tomino, Y
    [J]. INTERNAL MEDICINE, 2000, 39 (08) : 603 - 603
  • [5] Diagnostics and Therapy of Antineutrophil Cytoplasmic Antibody (ANCA) Associated Vasculitides
    Reinhold-Keller, Eva
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2012, 18 (29) : 4537 - 4541
  • [6] Clinical Significance of a Positive Antineutrophil Cytoplasmic Antibody (ANCA) Test
    Bui, Viet L.
    Kermani, Tanaz A.
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2016, 316 (09): : 984 - 985
  • [7] WEGENERS GRANULOMATOSIS - ANTINEUTROPHIL CYTOPLASMIC ANTIBODY HSI (ANCA) - REPLY
    WATSON, M
    [J]. JOURNAL OF LARYNGOLOGY AND OTOLOGY, 1990, 104 (08): : 668 - 668
  • [8] ANCA (Antineutrophil cytoplasmic antibody) positive Glomerulonephritis in Children 1800
    D Franzon
    J Lemire
    V Reznik
    H Krous
    W R Griswold
    [J]. Pediatric Research, 1998, 43 (Suppl 4) : 307 - 307
  • [9] MONONEURITIS MULTIPLEX AND VASCULITIS - ASSOCIATION WITH ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA)
    KAFKA, SP
    CONDEMI, JJ
    MARSH, D
    LEDDY, JP
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 1993, 91 (01) : 230 - 230
  • [10] ATYPICAL PRESENCE OF ANTINEUTROPHIL CYTOPLASMIC ANTIBODY (ANCA) IN INFECTIVE GLOMERULONEPHRITIS
    Reddy, Swetha
    Chakkera, Harini
    Ryan, Margaret
    Rice, Brea
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 2020, 75 (04) : 623 - 623